Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;26(1):17-26.
doi: 10.1097/EDE.0000000000000213.

Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth

Affiliations

Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth

Pauline Mendola et al. Epidemiology. 2015 Jan.

Abstract

Background: Preeclampsia is characterized by alterations in angiogenic factors that may increase neonatal morbidity independent of preterm birth.

Methods: We estimated the controlled direct effect of preeclampsia on neonatal outcomes independent of preterm birth among 200,103 normotensive and 10,507 preeclamptic singleton pregnancies in the Consortium on Safe Labor (2002-2008). Marginal structural models with stabilized inverse probability weights accounted for potential confounders in the pathway from preeclampsia to preterm birth to neonatal outcomes, including mediator-outcome confounders related to preeclampsia status, such as cesarean delivery. Controlled direct effects of preeclampsia on perinatal mortality, small for gestational age (SGA), neonatal intensive care unit (NICU) admission, respiratory distress syndrome, transient tachypnea of the newborn, anemia, apnea, asphyxia, peri- or intraventricular hemorrhage, and cardiomyopathy were estimated for the hypothesized intervention of term delivery for all infants.

Results: When delivery was set at ≥37 weeks, preeclampsia increased the odds of perinatal mortality (odds ratio = 2.2 [95% confidence interval = 1.1-4.5], SGA = (1.9 [1.8-2.1]), NICU admission (1.9 [1.7-2.1]), respiratory distress syndrome (2.8 [2.0-3.7], transient tachypnea of the newborn (1.6 [1.3-1.9]), apnea (2.2 [1.6-3.1]), asphyxia (2.7 [1.5-4.9]), and peri- or intraventricular hemorrhage (3.2 [1.4-7.7]). No direct effect of preeclampsia at term was observed for anemia or cardiomyopathy. Our results appear robust in the presence of moderate confounding, and restriction to severe preeclampsia yielded similar findings.

Conclusion: Preeclampsia was directly associated with adverse neonatal outcomes beyond morbidity mediated by preterm birth. Although severe neonatal outcomes were less common at later gestational ages, marginal structural models suggested elevated neonatal risk due to preeclampsia even if it was possible to deliver all infants at term.

PubMed Disclaimer

Figures

FIGURE.
FIGURE.
Potential confounders of the preeclampsia-preterm birth (<37 weeks)-neonatal health relationship included in the calculation of weights for the marginal structural model. X represents confounders of the preeclampsia-neonatal outcome association and preeclampsia-preterm birth association: study site, maternal age, race/ethnicity, insurance status, marital status, prepregnancy body mass index, parity, and maternal chronic diseases. W represents confounders of the preterm birth-neonatal outcome association that are affected by prior exposure to preeclampsia: fetal macrosomia, fetal distress/compromise, placental abruption, and cesarean delivery. Z represents confounders of the preterm birth-neonatal outcome association not included in X: chorioamnionitis, placenta previa, major fetal anomaly, maternal HIV positivity, maternal genital herpes, oligo- and polyhydramnios, other maternal or fetal reasons for delivery. U represents an unmeasured confounder.

Comment in

Similar articles

Cited by

References

    1. Lindheimer MD, Taler SJ, Cunningham FG. ASH position paper: hyper-tension in pregnancy. J Clin Hypertens (Greenwich). 2009;11:214–225. - PMC - PubMed
    1. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683. - PubMed
    1. Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355: 992–1005. - PubMed
    1. Wang A, Holston AM, Yu KF, et al. Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates. J Matern Fetal Neonatal Med. 2012;25:1447–1452. - PMC - PubMed
    1. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31:33–46. - PMC - PubMed

Publication types